Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases
Clinical trial NCT04752059 · COMPLETED
Trial details
- NCT number
- NCT04752059
- Sponsor
- Medical University of Vienna
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-28
- Primary completion
- 2023-05-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.